Mission:
The mission of the Spinal Muscular Atrophy Foundation is to accelerate the development of a treatment for SMA, the number one genetic killer of infants and toddlers.
About Us
More about SMA Foundation Leadership: Board of Directors, Scientific Advisory Board, Foundation Team
For one page overview of the SMA Foundation, please click here.
Foundation Goals
To help speed the realization of a treatment or cure, the SMA Foundation is committed to:- Developing private sector involvement in SMA drug development by fostering alliances between academia, government, and pharmaceutical and biotechnology companies
- Increasing government funding and support through targeted efforts to increase Congressional and NIH awareness
- Raising awareness of SMA among government leaders, members of the pharmaceutical and biotechnology industries, and the public at large
2008 Annual Report and Strategic Review
For a report on the Foundation's contributions to progress in therapeutics development for SMA, click here. Many thanks to all of our supporters, advisors and donors for helping us make the last years so productive. We hope you will join us in looking forward to the promise of a treatment for SMA in the near future.
To read the 2007 Annual Report, click here.
To read the 2006 Annual Report, click here.
To read the 2005 Annual Report, click here.
Structure & Governance
The Spinal Muscular Atrophy Foundation is a 501(c)3 tax exempt organization and a publicly supported charity as determined by the Internal Revenue Service. Therefore, the Foundation accepts contributions from individuals and from public and private grant-making organizations. Operations and expenditures are supervised by a Board of Directors. Our Advisory Board provides strategic guidance and advises the Foundation on all research grant investments.
Register to receive updates about the SMA Foundation and SMA research.
